{"id":"W2117722893","doi":"10.1186/2008-2231-21-50","title":"Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments","year":2013,"lang":"en","type":"article","venue":"DARU Journal of Pharmaceutical Sciences","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Interferon beta-1b; Quality-adjusted life year; Interferon beta-1a; Interferon beta; Biosimilar; Quality of life (healthcare); Cost effectiveness; Relapsing remitting; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01045429,0.001647371,0.003239284,0.002292171,0.0005046478,0.002415434,0.001688269,0.002281842,0.004830643],"category_scores_gemma":[0.01971672,0.00108482,0.004658425,0.001181856,0.0009493876,0.00186915,0.001238799,0.00235719,0.0001674465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006217587,"about_ca_system_score_gemma":0.003923485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008831855,"about_ca_topic_score_gemma":0.004377303,"domain_scores_codex":[0.995,0.003785294,0.0001544815,0.0003477189,0.0002819563,0.0004305983],"domain_scores_gemma":[0.9718801,0.02527376,0.00127299,0.0001982877,0.0005421864,0.000832666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.004998728,0.0004139416,0.006291195,0.0003614863,0.0006665947,0.0001565626,0.00003727539,0.9749819,0.0001706909,0.002622556,0.0004645774,0.008834394],"study_design_scores_gemma":[0.0004580006,0.001261454,0.002539493,0.0001238147,0.0007166248,0.0000792448,0.00006846486,0.991685,0.0001423771,0.002672177,0.0002226425,0.00003074819],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9383708,0.006834749,0.04370867,0.002559283,0.0001606462,0.001386671,0.001841991,0.0000997004,0.005037531],"genre_scores_gemma":[0.9926994,0.000862456,0.004850286,0.0001429585,0.00003015807,0.0003203226,0.0004927674,0.000008676177,0.0005930186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01045429,"threshold_uncertainty_score":0.05528826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3454514862041025,"score_gpt":0.4921742077763072,"score_spread":0.1467227215722047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}